Weight gain can impact patient’s quality of life and put them at risk for health complications. While weight loss can be an important factor in a patient’s health, it is equally important that it is done safely and effectively. Listen in as host, Geoff Wall compares the safety and efficacy of semaglutide and liraglutide in weight loss.
The GameChanger:
Show Segments:
00:00 – Introductions
01:10 – GLP-1s Agonist (Semaglutide vs Liraglutide) in Weight Management
10:00 – Change in Body Weight
12:02 – Secondary Outcomes – Blood Pressure, Blood Sugar, Lipid Concentrations, & Serum Insulin
12:59 – Safety & Side Effects
14:15 – Cost
14:52 – The GameChanger
17:20 – Closing Remarks
Links to Resources:
How to Claim CE:
CE is available for CEimpact members:
· Click here to claim CPE Credit
· Click here to claim CME Credit
Need a membership?
Continuing Education Information:
Learning Objectives:
1. Describe the inclusion and exclusion criteria of the STEP 8 study
2. Discuss the outcomes of the STEP 8 study
Dr. Wall is a member of the Janssen Speaker's Bureau.
0.05 CEU | 0.5 Hrs
ACPE UAN: 0107-0000-22-088-H01-P
Initial release date: 02/14/22
Expiration date: 02/14/2023
Additional CPE & CME details can be found here"